Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;15(8):905-12.
doi: 10.1016/S1473-3099(15)70152-0. Epub 2015 Apr 21.

Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study

Danielle V Clark  1 , Hannah Kibuuka  2 , Monica Millard  2 , Salim Wakabi  2 , Luswa Lukwago  3 , Alison Taylor  2 , Michael A Eller  4 , Leigh Anne Eller  4 , Nelson L Michael  5 , Anna N Honko  6 , Gene G Olinger Jr  6 , Randal J Schoepp  7 , Matthew J Hepburn  8 , Lisa E Hensley  6 , Merlin L Robb  4
Affiliations

Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study

Danielle V Clark et al. Lancet Infect Dis. 2015 Aug.

Abstract

Background: The limited data available for long-term Ebola virus disease health outcomes suggest that sequelae persist for longer than 1 year after infection. The magnitude of the present outbreak in west Africa necessitates a more complete understanding of the health effects and future medical needs of these patients.

Methods: We invited adult survivors of the 2007 Bundibugyo Ebola virus outbreak in Uganda and their contacts to take part in an observational study roughly 29 months after the outbreak. We collected information about health status, functional limitations, and demographics. We collected blood samples for clinical chemistry, haematology, and filovirus antibodies using ELISA. Analyses were restricted to probable and confirmed survivors and their seronegative contacts.

Findings: We recruited 70 survivors of the 2007 Bundibugyo Ebola virus and 223 contacts. We did analyses for 49 probable and confirmed survivors and 157 seronegative contacts. Survivors of the Bundibugyo Ebola virus were at significantly increased risk of ocular deficits (retro-orbital pain [RR 4·3, 95% CI 1·9-9·6; p<0·0001], blurred vision [1·9, 1·1-3·2; p=0·018]), hearing loss (2·3, 1·2-4·5; p=0·010), difficulty swallowing (2·1, 1·1-3·9; p=0·017), difficulty sleeping (1·9, 1·3-2·8; p=0·001), arthralgias (2·0, 1·1-3·6; p=0·020), and various constitutional symptoms controlling for age and sex. Chronic health problems (prevalence ratio [PR] 2·1, 95% CI 1·2-3·6; p=0·008) and limitations due to memory loss or confusion (PR 5·8, 1·5-22·4; p=0·010) were also reported more frequently by survivors of Bundibugyo Ebola virus.

Interpretation: Long-term sequelae persist for more than 2 years after Ebola virus disease. Definition of health consequences related to Ebola virus disease could improve patient care for survivors and contribute to understanding of disease pathogenesis.

Funding: Chemical Biological Technologies Directorate, Defense Threat Reduction Agency.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

  • Potential Impact of Sexual Transmission on Ebola Virus Epidemiology: Sierra Leone as a Case Study.
    Abbate JL, Murall CL, Richner H, Althaus CL. Abbate JL, et al. PLoS Negl Trop Dis. 2016 May 2;10(5):e0004676. doi: 10.1371/journal.pntd.0004676. eCollection 2016 May. PLoS Negl Trop Dis. 2016. PMID: 27135922 Free PMC article.
  • Ebola virus disease and critical illness.
    Leligdowicz A, Fischer WA 2nd, Uyeki TM, Fletcher TE, Adhikari NK, Portella G, Lamontagne F, Clement C, Jacob ST, Rubinson L, Vanderschuren A, Hajek J, Murthy S, Ferri M, Crozier I, Ibrahima E, Lamah MC, Schieffelin JS, Brett-Major D, Bausch DG, Shindo N, Chan AK, O'Dempsey T, Mishra S, Jacobs M, Dickson S, Lyon GM 3rd, Fowler RA. Leligdowicz A, et al. Crit Care. 2016 Jul 29;20(1):217. doi: 10.1186/s13054-016-1325-2. Crit Care. 2016. PMID: 27468829 Free PMC article. Review.
  • Molecular mechanisms of Ebola pathogenesis.
    Rivera A, Messaoudi I. Rivera A, et al. J Leukoc Biol. 2016 Nov;100(5):889-904. doi: 10.1189/jlb.4RI0316-099RR. Epub 2016 Sep 1. J Leukoc Biol. 2016. PMID: 27587404 Free PMC article. Review.
  • Ebola virus disease.
    Jacob ST, Crozier I, Fischer WA 2nd, Hewlett A, Kraft CS, Vega MA, Soka MJ, Wahl V, Griffiths A, Bollinger L, Kuhn JH. Jacob ST, et al. Nat Rev Dis Primers. 2020 Feb 20;6(1):13. doi: 10.1038/s41572-020-0147-3. Nat Rev Dis Primers. 2020. PMID: 32080199 Free PMC article. Review.
  • Post-COVID symptoms are associated with endotypes reflecting poor inflammatory and hemostatic modulation.
    An AY, Baghela A, Zhang PGY, Blimkie TM, Gauthier J, Kaufmann DE, Acton E, Lee AHY, Levesque RC, Hancock REW. An AY, et al. Front Immunol. 2023 Aug 23;14:1243689. doi: 10.3389/fimmu.2023.1243689. eCollection 2023. Front Immunol. 2023. PMID: 37680625 Free PMC article.
See all "Cited by" articles

Publication types